KIMBERLY HAGEN: Open Payments
NPI 1811555709 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 14 payments from 12 companies in 2025. Trend: 2023 $109 · 2024 $2,716 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Boston Scientific Corporation | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: LEQVIO, WATCHMAN FLX, ONPATTRO, FUROSCIX, Assure WCD, SAPIEN 3 Ultra RESILIA, JARDIANCE, REPATHA.
Industry payments across NJ — which companies pay providers there.
